Ignite Creation Date:
2025-12-24 @ 1:18 PM
Ignite Modification Date:
2026-01-03 @ 2:45 PM
Study NCT ID:
NCT04352595
Status:
COMPLETED
Last Update Posted:
2024-03-01
First Post:
2020-03-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients
Sponsor:
Tianjin Hemay Pharmaceutical Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-02
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-20
First Submit QC Date:
None
Study First Post Date:
2020-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-29
Last Update Post Date:
2024-03-01
Last Update Post Date Type:
ACTUAL